Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

Treatment for Pulmonary Arterial Hypertension: Oxygen Therapy for Respiratory Failure01:16

Treatment for Pulmonary Arterial Hypertension: Oxygen Therapy for Respiratory Failure

Oxygen therapy has emerged as a significant tool in enhancing the quality of life for patients suffering from pulmonary arterial hypertension (PAH). While this therapy has principally been studied on patients with significant hypoxemia, this therapeutic approach helps prevent potential organ damage and can be administered in the comfort of one's home.
Oxygen therapy is vital in increasing and maintaining blood oxygen levels in PAH patients. As a result, it aids in reducing fatigue, improving...
Chronic Obstructive Pulmonary Disease-IV: Assessement and Diagnostic Studies01:27

Chronic Obstructive Pulmonary Disease-IV: Assessement and Diagnostic Studies

Assessing and diagnosing Chronic Obstructive Pulmonary Disease (COPD) involves a detailed approach that includes a comprehensive review of medical history, physical examination, and a variety of diagnostic tests. This thorough evaluation is essential to ensure an accurate diagnosis and guide effective management strategies.
Medical History
Cardiac Catheterization II: Right Heart Catheterization01:21

Cardiac Catheterization II: Right Heart Catheterization

Right Heart Catheterization: An OverviewRight heart catheterization is an invasive diagnostic procedure that measures right-sided cardiac and pulmonary artery pressures, calculates cardiac output, and identifies intracardiac shunts. It provides detailed hemodynamic data essential for diagnosing and managing various cardiovascular conditions, such as pulmonary hypertension.Access SitesCommon access sites for right heart catheterization include the internal jugular vein in the neck region, the...
Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care01:29

Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care

Diagnosing Pulmonary EmbolismDiagnosing pulmonary embolism (PE) involves clinical assessment and advanced imaging tests. The preferred diagnostic tool is the spiral (helical) CT scan or CT angiography (CTA), which uses intravenous contrast media to visualize the pulmonary vasculature and identify emboli.A ventilation-perfusion (V/Q) scan is an alternative for patients unable to receive contrast media. This scan includes both perfusion and ventilation scanning. Perfusion scanning involves...

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

A Randomized Controlled Trial of No Routine Gastric Residual Monitoring to Guide Enteral Feeding in PICUs: Statistical Analysis Plan for the GASTRIC-PICU Trial.

Pediatric critical care medicine : a journal of the Society of Critical Care Medicine and the World Federation of Pediatric Intensive and Critical Care Societies·2026
Same author

Gastric Residual Volume Assessment in Critically Ill Children: The GASTRIC-PICU Randomized Clinical Trial.

JAMA·2026
Same author

Protocolized Evaluation of Permissive Blood Pressure Targets Versus Usual Care (PRESSURE): Statistical Analysis Plan for the PRESSURE Trial.

Pediatric critical care medicine : a journal of the Society of Critical Care Medicine and the World Federation of Pediatric Intensive and Critical Care Societies·2026
Same author

Six-Month Outcomes of a Trial of Potassium Supplementation Thresholds After Cardiac Surgery.

JAMA·2026
Same author

Correction: How would Marie Kondo design a protocol? In favor of subtractive change in clinical trials.

Frontiers in medicine·2026
Same author

How would Marie Kondo design a protocol? In favor of subtractive change in clinical trials.

Frontiers in medicine·2026

相关实验视频

Updated: Jul 15, 2026

Increasing Pulmonary Artery Pulsatile Flow Improves Hypoxic Pulmonary Hypertension in Piglets
08:08

Increasing Pulmonary Artery Pulsatile Flow Improves Hypoxic Pulmonary Hypertension in Piglets

Published on: May 11, 2015

评估肺动脉导管在重症监护病人的管理中的临床有效性 (PAC-Man):一个随机对照试验.

Sheila Harvey1, David A Harrison, Mervyn Singer

  • 1Intensive Care National Audit and Research Centre, London, UK.

Lancet (London, England)
|August 9, 2005
PubMed
概括

这项研究发现,在用肺动脉导管 (PAC) 或不使用肺动脉导管 (PAC) 治疗的重症患者中,医院死亡率没有显著差异. 需要进一步的研究来确定PAC是否在特定的患者群体中提供好处.

更多相关视频

Utilizing Percutaneous Ventricular Assist Devices in Acute Myocardial Infarction Complicated by Cardiogenic Shock
06:10

Utilizing Percutaneous Ventricular Assist Devices in Acute Myocardial Infarction Complicated by Cardiogenic Shock

Published on: June 12, 2021

Isolated Lung Perfusion System in the Rabbit Model
10:18

Isolated Lung Perfusion System in the Rabbit Model

Published on: July 15, 2021

相关实验视频

Last Updated: Jul 15, 2026

Increasing Pulmonary Artery Pulsatile Flow Improves Hypoxic Pulmonary Hypertension in Piglets
08:08

Increasing Pulmonary Artery Pulsatile Flow Improves Hypoxic Pulmonary Hypertension in Piglets

Published on: May 11, 2015

Utilizing Percutaneous Ventricular Assist Devices in Acute Myocardial Infarction Complicated by Cardiogenic Shock
06:10

Utilizing Percutaneous Ventricular Assist Devices in Acute Myocardial Infarction Complicated by Cardiogenic Shock

Published on: June 12, 2021

Isolated Lung Perfusion System in the Rabbit Model
10:18

Isolated Lung Perfusion System in the Rabbit Model

Published on: July 15, 2021

科学领域:

  • 关键护理医学 关键护理医学
  • 心血管监测 心血管监测
  • 临床试验 临床试验

背景情况:

  • 肺动脉导管 (PAC) 是重症监护中的常见血液动力学监测工具.
  • 关于PAC使用的安全性和有效性的担忧仍然存在.
  • 这项研究旨在评估PAC管理对重症患者医院死亡率的影响.

研究的目的:

  • 确定使用肺动脉导管 (PAC) 是否可以降低重症患者在医院的死亡率.
  • 评估PAC插入和管理的安全概况.

主要方法:

  • 这是一项随机对照试验,涉及65个英国重症监护病房的1041名患者.
  • 患者被分配到具有 (n=519) 或没有 (n=522) PAC 的管理.
  • 临床管理决策由治疗临床医生自行决定.

主要成果:

  • 在PAC和对照组之间没有观察到医院死亡率的显著差异 (68%与66%,p=0.39).
  • 在486名患者中,有46名患者出现了PAC插入的并发症,没有致命的结果.
  • 在使用PAC时,调整后的死亡风险比为1.09 (95%CI为0.94-1.27).

结论:

  • 目前的证据不支持使用PAC管理重症患者的明显益处或危害.
  • 需要进行进一步的疗效研究,以确定可能受益于PAC管理协议的特定患者亚组.
  • 如果在特定人群中没有证明有效性,PACs可能会变得过时.